Philadelphia, May 10, 2022 – Using an artificial intelligence (AI) tool that emulates how humans visualize and is trained to recognize and classify images, investigators constructed a model that predicts the postoperative recurrence of Crohn disease with high accuracy by evaluating histological images. The AI tool also revealed previously unrecognized differences in adipose cells and significant differences in the extent of mast cell infiltration in the subserosa, or outer lining of the intestine, comparing patients with and without disease recurrence. The findings appear in The American Journal of Pathology, published by Elsevier.
Trending
- Natera acquires Foresight Diagnostics for up to $450M (Medtech Dive)
- $4.2M CDC grant to increase colorectal cancer screening in Pennsylvania (PennState)
- Motility coding changes coming in the new year (AGA)
- Updated Crohn’s Disease Guideline Stresses Early Use of Advanced Drugs (Medscape)
- Check your final 2025 MIPS eligibility (AGA)
- Affordable Care Act subsidies appear likely to expire (Chief Healthcare Executive)
- AI scribes hold ‘transformative potential’ for improving physician burden, patient care (Healio)
- New York Gastroenterology Associates Taps Proscia for Digital Pathology (Bio.IT World)
